Patients with overactive bladder syndrome-wet (OAB-wet) experience urgency urinary incontinence, particularly urinary frequency and nocturia. Nocturnal enuresis (NE) is less addressed among OAB-wet patients.
Kuan Chong Ng +2 more
doaj +1 more source
OnabotulinumtoxinA in the treatment of neurogenic bladder
Aziz Gulamhusein, Altaf MangeraDepartment of Urology Research, Sheffield Teaching Hospitals NHS Trust, Royal Hallamshire Hospital, Sheffield, United KingdomAbstract: This review examines the evidence for use of onabotulinumtoxinA in the treatment of ...
Gulamhusein A, Mangera A
doaj
Mitochondrial stress and activation of PI3K and Akt survival pathway in bladder ischemia
Jing-Hua Yang,1 Mike B Siroky,1 Subbarao V Yalla,2 Kazem M Azadzoi3,4 1Department of Urology, VA Boston Healthcare System, Boston University School of Medicine, 2Department of Urology, VA Boston Healthcare System, Harvard Medical School, 3Department of ...
Yang JH, Siroky MB, Yalla SV, Azadzoi KM
doaj
Detrusor after-contraction on ambulatory urodynamics in symptomatic women
ObjectivesTo investigate the association between detrusor after-contraction and urodynamic parameters in a cohort of patients undergoing urodynamic studies by ambulatory monitoring.MethodsAll symptomatic adult female patients with non-neurogenic lower ...
Leonard A +5 more
core +1 more source
Botulinum toxin therapy for neurogenic detrusor overactivity.
Detrusor injection of botulinum toxin (BTX) has shown great promise in the treatment of neurogenic detrusor overactivity (NDO) refractory to conservative therapy.
Smaldone, Marc C +2 more
core +1 more source
Ice Water Test Unmasks Detrusor Overactivity in Apparently Normal Conventional Cystometry. [PDF]
Stächele L +9 more
europepmc +1 more source
Upregulation of aquaporin-2 and caveolins in rat bladder with outlet obstruction-induced detrusor overactivity. [PDF]
Yu SH, Chung HS, Lim DG, Kim SO.
europepmc +1 more source
Urodynamic characteristics and clinical significance of detrusor overactivity in early (≤6 months) male urinary incontinence following TURP and RARP: a descriptive analysis of two cohorts. [PDF]
Zeng X, Shen H, Luo D, Jin T.
europepmc +1 more source
Population Pharmacokinetic and Pharmacodynamic Modeling of Fesoterodine in Pediatric Patients with Neurogenic Detrusor Overactivity. [PDF]
Sano Y +5 more
europepmc +1 more source
Urodynamic and Anamnestic Predictors for Individual Dose Adjustment of Intravesical Oxybutynin in Neurogenic Detrusor Overactivity: Results From the UPSIDE Study. [PDF]
Van Ophoven A +16 more
europepmc +1 more source

